Background: Suspicion of an acute allergic reaction is a common reason for attending the emergency department (ED). However, there are few comparisons between the initial diagnosis of suspected allergic reaction made in the ED with the definitive diagnosis made subsequently in the allergy department (AD). Objective: To compare details of the initial diagnosis made in the ED relating to allergy with the final diagnosis made in the AD. Methods: Patients attending the ED of 2 hospitals with suspected allergic reactions were prospectively enrolled based on key words. A certified allergy specialist reviewed the ED records of these patients and, if these were suggestive of an allergic reaction, the patients were scheduled for further evaluation at the allergy clinic. Results: In total, 2000 patients were enrolled between April 2013 and October 2015. Of these, 1333 passed the initial assessment and underwent further evaluation. Of the 1333 patients, 528 underwent an allergological study, and 206 were confirmed as being allergic. With respect to drug allergy, nonsteroidal anti-inflammatory drugs were the most common triggers, followed by β-lactams; in food allergy, plant-based foods were the most common. Only 16.4% of patients confirmed as having anaphylaxis in the AD were initially diagnosed with the condition in the ED. Conclusion: Of the 528 patients who finally underwent the full allergological study, fewer than half were confirmed as allergic. Moreover, anaphylaxis appears to be underdiagnosed in the ED. Better communication between the ED and the AD is necessary to improve the diagnosis and management of these patients.
Introduction
Allergic reactions are acute medical events resulting from abnormal immunological hyperreactivity, generally to proteins or drugs. They generate a significant clinical burden in primary care departments. In the case of food allergy, common triggers include cow's milk, egg, wheat, soy, peanut, tree nuts, fish, shellfish, and fruits [1] [2] . In the case of drug hypersensitivity reactions (DHRs), key triggers include nonsteroidal antiinflammatory drugs (NSAIDs) and antibiotics [3] [4] . The clinical presentation of allergic reactions varies considerably. However, they are usually acute and severe, with urticaria, angioedema, and anaphylaxis being the most common signs [5] [6] [7] [8] .
Suspicion of allergic reactions is a major presenting complaint in the emergency department (ED). Allergic reactions generate significant costs for the health care system. In the USA, the estimated direct cost of food-induced allergic reactions and anaphylaxis was $227 million in 2007 [9] . Furthermore, recognition and treatment of anaphylaxis in the ED is often undermined by atypical presentation and a lack of adequate training among primary care physicians [10] . These concerns underline the need for better management of food allergy and DHRs by ED physicians.
Few studies have prospectively analyzed the diagnosis of patients presenting at the ED with a suspicion of allergy and subsequently compared those results with those of a standard outpatient evaluation by an allergist. Most previous studies focused on anaphylaxis [11] [12] . Here, we used a multistep approach to screen ED patients for potential allergic reactions and compared the ED diagnosis with the final results from the allergology department. Our analysis was based on clinical characteristics and the most common triggers.
Methods

Study Design
We conducted a prospective study of patients aged ≥14 years who attended the ED of 2 hospitals in Málaga, Spain between April 2013 and June 2015. As an initial screening evaluation, the electronic medical records of patients who sought assistance at either of the EDs were screened for specific key words. In the next step (primary evaluation), a certified allergist analyzed the ED electronic medical records of the patients who underwent the screening evaluation and contacted them by telephone to obtain additional details. Those suspected of having experienced an allergic reaction proceeded to the last step (final evaluation), which involved an extensive allergological work-up in our unit by 1 of 2 certified allergists who were not involved in the primary evaluation (Figure) .
Data collected by the ED physician from patients selected in the screening evaluation were compared with those obtained from patients selected in the primary evaluation. Data from patients selected in the primary evaluation were also compared with those obtained from the allergological work-up in the final evaluation.
The study was conducted according to the principles of the Declaration of Helsinki and approved by the Provincial Investigational Ethics Committee of Malaga. All the participants were informed orally about the allergological workup and signed the corresponding informed consent document.
Screening Evaluation (Key Word Search)
The reason for consultation and the final diagnosis at the ED visit were screened for a possible match to a predetermined key word bank (allergy, hypersensitivity, allergic reaction, urticaria, cutaneous eruption, infection, dermatitis, exanthema, anaphylaxis, reaction, angioedema, adverse event, insect sting, erythema, pruritus, drug intolerance, asthma, and food intoxication) to search for possible allergic diseases.
Primary Evaluation
A single, certified allergist performed the primary evaluation within 10 days of the ED visit. Patients with a suspected allergic reaction (suggestive symptoms and/or suggestive time interval between allergen contact/intake and reaction) were selected. A standardized data collection form was used to record demographical and clinical data, including allergy and asthma history, identification of the number and the type of culprit allergens, timing of the reaction, presenting signs and symptoms, and management by an ED physician. The diagnosis as reported by the ED physician was categorized into one of the following groups: food allergy, DHR, food plus drug allergy, dermatological disease, other allergy, angioedema (without urticaria), idiopathic urticaria, and other diseases.
Final Evaluation
All patients selected in the first evaluation were offered an allergological work-up at the outpatient Allergy Unit. This formal evaluation was initiated within 4 weeks of the ED visit and completed by a different allergist to the one who performed the primary evaluation. If necessary, we performed skin prick tests (SPTs), intradermal tests (IDTs), measurement of specific IgE (sIgE) by ImmunoCAP (Thermo Fisher Scientific), the basophil activation test (BAT), doubleblind placebo-controlled food challenge (DBPCFC), and/or single-blind placebo-controlled drug provocation test (DPT). on separate days and prepared immediately before the challenge. Up to 5 doses were administered at 20-minute intervals until the intended cumulative dose was reached. After the last dose, the patient remained in observation for at least 2 hours.
DHR was investigated using DPT performed at the Allergy Unit. If negative, a 2-day course of outpatient therapy with the culprit drug was administered as described elsewhere [19, 21] .
Statistical Methods
Confidence intervals for descriptive data were calculated using a modified Wald method. The 2-tailed Fisher exact test was used to analyze nominal variables. Means between groups were compared using paired t tests. Agreement on diagnosis between 2 observers was quantified using the Cohen κ statistic. All analyses were performed using GraphPad PRISM version 6.0b (GraphPad).
Results
Our ED department provides care for approximately 450 000 patients each year; most of these patients live in the province of Malaga. Two thousand patients (0.22% of Diagnosis of anaphylaxis was based on the European Academy of Allergy and Clinical Immunology (EAACI) guidelines [13] . Participants with DHR were classified according to previous guidelines [14] [15] . They were also classified based on the time to response as immediate responders (<1 hour after drug administration) or nonimmediate responders (>1 hour).
Skin Testing
Food allergy was investigated using SPT performed according to European guidelines [16] with commercialized allergen extracts (ALK-Abelló). The response was considered positive if the diameter of the wheal was 3 mm greater than the saline control. DHR was investigated using SPT with the culprit drug and, if the result was negative, by IDT, as recommended. The dosages for the different drugs were as described previously [17] .
In Vitro Testing sIgE levels were determined by ImmunoCAP following the manufacturer's recommendations. Results were expressed as kU A /L and considered positive when >0.35 kU A /L [18] . BAT was performed as described [19] , including different concentrations of the suspected allergen or drug. The results were presented as the percentage of activated basophils (CD63
Provocation Test
Food allergy was investigated using DBPCFC performed at the Allergy Unit following EAACI recommendations [20] . Blinded active and placebo meals were randomly administered Figure) . A comparison of patients who underwent the final allergological work-up with those who did not complete the full process for various reasons revealed gender differences. A higher proportion of females underwent the final studies (P=.008). In addition, women were also more likely to have a prior history of allergy (P<.0001)-specifically to aeroallergens (P<.0001)-a presumptive diagnosis of DHR (P<.0001), anaphylaxis (P=.023), and specific triggers such as β-lactams (P=.009), NSAIDs (P<.0001), and contrast media (P=.019). All comparisons are detailed in Table 3 .
Among participants who underwent the allergological work-up, 40.9% were diagnosed with idiopathic urticaria. Food allergy was recorded in 86 patients (16.3%), of whom 24 (28.6%) had previously been diagnosed as allergic to the food that caused the ED visit. Among these 86 food-allergic patients, 84 (97.6%) had reactions triggered only by food, whilst 2 (2.4%) presented a reaction that could be attributed to both food and drugs (lipid transfer protein and amoxicillin). For these 86 participants, diagnosis was achieved by SPT (72.1%) and determination of sIgE (27.9% 7%) had a concomitant reaction after the intake of 2 different drugs: acetaminophen and ibuprofen in both cases. The most frequent triggers were NSAIDs, affecting 72 patients (62.1%), followed by β-lactams in 26 patients (22.4%) and quinolones and radiocontrast media in 6 patients (5.2%). The comparison of data after the final evaluation with those obtained from the primary evaluation showed an increase in the percentage of cases reporting only 1 culprit drug (87.7% vs 98.3%; P=.032). No statistically significant differences were found when clinical symptoms, timing of the reaction, and identified triggers were analyzed (Table 5) .
Among the 72 patients with confirmed hypersensitivity to NSAIDs after the final evaluation, 12 (16.7%) were already known to be NSAID-hypersensitive before their ED visit. Seventy patients were diagnosed by DPT; 2 were diagnosed by SPT to dipyrone. The clinical presentation reported after NSAID intake was urticaria/angioedema (32 . Dipyrone was the most common trigger, affecting 38 patients (52.8%), followed by propionic acids (namely ibuprofen) in 14 patients (19.4%), naproxen in 6 patients (8.3%), dexketoprofen in 4 patients (5.6%), diclofenac in 8 patients (11.1%), and aspirin in 2 patients (2.8%).
Among the 26 patients confirmed as having β-lactam allergy, 4 (15.4%) were already known to be hypersensitive to β-lactams before the ED visit. Diagnosis was established by IDT for 14 (53.8%) patients, BAT for 4 (15.4%), and DPT for 8 (30.8%). The clinical presentation after β-lactam intake-as 1.8%] ). In the case of patients who developed an anaphylactic reaction induced by drugs (46 [41.8%] of the total 110 cases of anaphylaxis), the culprits were (in descending order) NSAIDs in 32 patients (29.1%), β-lactams in 12 (10.9%), and quinolones in 2 (3.6%). Among patients with hypersensitivity to NSAIDs, 26 (23.6%) were confirmed as having single NSAID-induced urticaria/angioedema or anaphylaxis and 6 (5.5%) as having NSAID-induced urticaria/ angioedema. In the case of β-lactam allergy, 4 patients (3.6%) were diagnosed as having cross-reactivity to β-lactams, 4 (3.6%) a selective allergy to amoxicillin, and 2 (1.8%) a selective allergy to clavulanic acid. Eight patients (7.3%) were diagnosed with idiopathic anaphylaxis and anaphylaxis induced by hymenoptera venom, latex allergy, exerciseinduced allergy, and mastocytosis (1.8%, respectively) (Supplementary Table 1) .
Of the 110 patients who met the criteria for anaphylaxis, only 18 (3.8%) were diagnosed as such in the ED. Moreover, inpatient treatment by ED physicians included epinephrine in 20 cases (18.8%), antihistamines in 82 (74.5%), and systemic corticosteroids in 88 (80%). Upon discharge, prescribed treatment included self-injectable epinephrine in 8 patients (7.2%), antihistamines in 90 (81.8%), and systemic corticosteroids in 48 (43.2%) (Supplementary Table 2) .
Agreement on diagnosis between ED physicians, trained allergists in the primary evaluation, and trained allergists in the final evaluation was measured using the Cohen κ statistic for all 528 fully evaluated cases. A concordant result was found between the ED physician and the allergist after the final evaluation in 246 of the 528 cases (46.6%; κ=0.325 [0.254-0.396]); a concordant result was found between the allergist in the primary evaluation and the other allergist in the final evaluation for 282 of the 528 cases (53.41%; κ=0.413 [0.343-0.482]).
Discussion
We assessed all patients attending the ED over a 2-year period using a key word-based screening evaluation, which yielded 2000 patients with a potential allergic disease. After excluding patients who were clearly not allergic, could not be contacted, or chose not to participate further, the final sample comprised 528 patients who completed the allergological work-up. These were mainly diagnosed with idiopathic urticaria (40.9%), DHR (22.0%), food allergy (16.3%), and dermatological conditions (10.2%).
Most of the initial 2000 participants were not assessed; in fact, only 26.4% completed the study. This relatively low rate of completion limits the power of the study, including the identification of statistically significant differences in characteristics such as allergen type. In addition to the 199 patients who were clearly not allergic and thus excluded at the primary evaluation, other patients did not complete the study owing to problems making and maintaining contact, as well as for reasons such as lack of interest, work commitments, and prohibitive distance. We compared demographic and clinical information between patients who were not studied and those who finally underwent the allergological work-up and found that women were more prone to be investigated. This is a well-documented phenomenon for various medical conditions [22] [23] . Interestingly, many of the patients diagnosed with anaphylaxis in the allergological work-up were diagnosed with urticaria/ angioedema in the ED. It may be the case that patients who themselves suspect a more severe reaction are more likely to attend their allergological work-up. On the other hand, a milder allergic presentation may discourage completion of the study; for example, a much higher percentage of dermatological disease was observed in patients who did not complete the assessment than in those who underwent the allergological work-up (Table 2) . Similarly, patients with DHRs, especially those reacting to NSAIDs and β-lactams, were more likely to undergo the final allergological work-up. This phenomenon could be explained by the lack of knowledge regarding these prevalent drug allergies in the study population, or perhaps the lack of alternative medicines means patients are keener to attend their appointments. This is an important point, as for many drugs, such as β-lactams, resistance and cost of alternatives are a major issue [24] .
Nonetheless, when we compared the prevalence of NSAID and β-lactam allergy, our results were similar to those of other authors [25] . More studies are necessary in EDs in other geographical locations before these findings can be extrapolated to the general population.
Furthermore, anaphylaxis was identified in 20.8% of the 528 participants who completed the allergological work-up. The condition was diagnosed through analysis of the clinical history based on the EAACI guidelines [26] . Food allergy and DHR accounted for 43.6% and 41.8%, respectively, of all anaphylaxis cases. The prevalence of food anaphylaxis found here agrees with that reported in other studies, ranging from 31.0% to 51.0% [27] [28] . However, the prevalence of drug-induced anaphylaxis appears to be slightly higher in our population, possibly owing to higher drug consumption or demographic differences. NSAIDs were most frequent culprits in the present study, consistent with data reported elsewhere [29] [30] .
Of the 528 patients finally evaluated in the allergological work-up, 110 were confirmed as having anaphylaxis. However, the term anaphylaxis was used in only 3.8% of electronic medical records in the ED. This is consistent with the finding that only 18.1% of the 110 confirmed patients with anaphylaxis were treated with epinephrine according to guidelines whilst in the ED. Moreover, less than half of these patients were discharged with a prescription for self-injectable epinephrine. In fact, various studies have shown that erroneous identification of anaphylaxis is a real issue in the ED and that around 57% of cases may be misdiagnosed and up to 80% undertreated [31] [32] [33] . Given that timely administration of epinephrine is essential for the effective treatment of anaphylaxis and that such treatment is dependent on the correct identification of cases, better training of ED physicians and better collaboration with the allergology department will ensure prompt recognition and better management [10] .
Analysis of agreement on diagnosis between the final evaluation from the allergology department and the initial primary evaluations and evaluations by ED physicians showed a moderate and fair correlation, respectively, with concordance values of 53.4% and 46.6%. Since primary evaluation depends on data available in electronic medical records, this is likely to explain the discrepancy between the primary and final evaluations, even though both are made by certified allergists. Interestingly, the trigger was not identified during the ED visit in 19.8% of the patients who underwent the allergological work-up. However, the complexity of identifying the trigger of an acute allergy reaction is well known [34] , and this finding should not necessarily be considered a deficiency of the ED.
After the final evaluation, only 69.72% of patients initially diagnosed with drug allergy and 76.24% of those diagnosed with food allergy in the ED were confirmed as nonallergic. In other words, a large percentage of patients are being overdiagnosed and therefore unnecessarily advised to avoid certain drugs and foods.
In summary, our results highlight the importance of educating primary care physicians about the clinical presentations of allergy, particularly with regards to anaphylaxis and its appropriate treatment with epinephrine. Similarly, food allergy and DHRs should be thoroughly assessed by a trained allergist in order to correctly identify triggers.
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